BassieNL schreef op 29 maart 2018 14:37:
[...]
Je bent te optimistisch... conditional approval staat in Q1 2019 gepland.
--
Kiadis Pharma submitted responses to the Day 120 List of Questions in March 2018 and is on track to potentially obtain a positive CHMP opinion for ATIR101 in
Q4 2018
and (conditional) approval from the European Commission in
Q1 2019,
which would allow for a European launch in H2 2019